Rheumatology Doctors in Provo, UT Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Dr. Wenshu Yu, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3650 N University Ave Ste 150, Provo, UT 84604 Phone: 801-818-1940    Fax: 801-818-1945

Malgorzata Hanczyc, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1055 N 500 W, Suite 212, Provo, UT 84604 Phone: 801-429-8095    Fax: 801-354-8265

Michael Darley, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1055 N 300 W Ste 303, Provo, UT 84604 Phone: 801-852-9600    Fax: 801-852-9695

Richard A Call Ii, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3651 No 100 E, Ste #150, Provo, UT 84604 Phone: 801-226-0737    Fax: 801-226-0832

News Archive

Lignans lower risk of death in women with breast cancer

Phytoestrogens are plant compounds which, in the human body, can attach to the receptors for the female sexual hormone estrogen and which are taken in with our daily diet. A number of findings have attributed a cancer protective effect to these plant hormones. At DKFZ, a team headed by Prof. Dr. Jenny Chang-Claude summarized the results of several studies in a meta-analysis last year and showed that a diet rich in phytoestrogens lowers the risk of developing breast cancer after menopause.

Hyperion's HPN-100 granted FDA Fast Track Designation for urea cycle disorders

Hyperion Therapeutics, Inc. announced today that its investigational compound glycerol phenylbutyrate (HPN-100) has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA) as adjunctive therapy for the chronic management of urea cycle disorders. Hyperion recently completed its phase III trial which was conducted under a Special Protocol Assessment (SPA) agreement with the FDA. The Company plans to announce results from that trial later this year.

SARS-CoV-2 suppresses ACE2 activity in COVID-19 patients

A recent study conducted by a team of international scientists has revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), suppresses the expression and function of human angiotensin-converting enzyme 2 (ACE2) and induces the expression of interferon-stimulated genes at the initial phase of infection. The study is currently available on the bioRxiv* preprint server.

Berkeley researchers search for cancer clues in sample of blood

One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring a panel of cancer proteins in rare, individual tumor cells that float in the blood.

VIB researchers develop mouse model for Charcot-Marie-Tooth neuropathy

VIB researchers have developed a mouse model for Charcot-Marie-Tooth (CMT) neuropathy, a hereditary disease of the peripheral nervous system.

Read more Medical News

› Verified 3 days ago